Research may have important implications for combating diabetes

December 11, 2012 by William G. Gilroy

(Medical Xpress)—Research by University of Notre Dame biochemist Anthony S. Serianni is providing new insights that could have important implications for understanding and treating diabetes.

Serianni points out that known as dicarbonyl sugars are produced inside the human body from the natural breakdown of the simple . The formation of these sugars is enhanced in diabetic patients because in the blood and plasma of diabetics are significantly elevated.

"We investigated, under laboratory conditions that approximate those in the body, the degradation of a specific dicarbonyl sugar called glucosone," Serianni says. "To establish with certainty the chemical fates of the individual carbons of the glucosone molecule during degradation, we replaced some of its carbons with a rare form of carbon (denoted 13C) and applied an analytical technique known as nuclear to observe at the molecular level how the individual 13C carbons behave as degradation occurred.

"We learned that glucosone degrades by an unanticipated that involves a novel rearrangement of the carbon backbone of the molecule, a process we call C1-C2 transposition."

The discovery undermines some prevailing assumptions about how sugars generally undergo degradation.

"Since sugar degradation in the body has important physiological implications—for example, by causing changes in that accompany aging and by producing highly reactive byproducts that damage cellular constituents—understanding how these molecules are transformed in the body is essential to understanding spontaneous that are not necessarily subject to typical cellular controls," Serianni says.

The research also demonstrates a new role for phosphate as a catalyst in sugar degradation, a role that may be more common in in vitro and in vivo biochemistry than currently appreciated.

The research is a culmination of prior studies that Serianni's research group has conducted on saccharide degradation and rearrangement. In 1982, his group discovered the first stereospecific C1-C2 transposition reaction of saccharides, catalyzed by molybdate ion, that resulted in a process called C2 epimerization. This work led to new and convenient synthetic pathways for the 13C-labeling of saccharides upon which a commercial business was founded.

Serianni's lab has also promoted the use of 13C and other isotopes as tools to investigate new chemical and biochemical reactions, to probe biological metabolism and to develop new clinical and diagnostic tools and tests.

"In this sense, the glucosone work fits nicely into our overall research mission," Serianni says.

The glucosone research was described in a study that appeared in the Journal of the American Chemical Society and was supported by the National Institute of Diabetes and Digestive and Kidney Disease.

Explore further: Scientists have way to control sugars that lead to diabetes, obesity

Related Stories

Scientists have way to control sugars that lead to diabetes, obesity

September 26, 2012
(Medical Xpress)—Scientists can now turn on or off the enzymes responsible for processing starchy foods into sugars in the human digestive system, a finding they believe will allow them to better control those processes ...

Team identifies key protein causing excess liver production of glucose in diabetes

September 28, 2011
Researchers at the John G. Rangos Sr. Research Center at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine have identified a powerful molecular pathway that regulates the liver's ...

Recommended for you

In a nutshell: Walnuts activate brain region involved in appetite control

August 17, 2017
Packed with nutrients linked to better health, walnuts are also thought to discourage overeating by promoting feelings of fullness. Now, in a new brain imaging study, researchers at Beth Israel Deaconess Medical Center (BIDMC) ...

Smart mat detects early warning signs of foot ulcers

August 16, 2017
While completing his residency in anesthesiology at Massachusetts General Hospital in the mid-2000s, Jon Bloom saw his fair share of foot amputations among patients with diabetes. The culprit: infected foot ulcers.

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New measure of insulin-making cells could gauge diabetes progression, treatment

August 10, 2017
Researchers at the University of Wisconsin-Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.

Pioneering immunotherapy shows promise in type 1 diabetes

August 9, 2017
It may be possible to 'retrain' the immune system to slow the progression of type 1 diabetes, according to results of a clinical trial published today in the journal Science Translational Medicine.

Online team-based game helps patients with diabetes lower blood glucose

August 8, 2017
Researchers from Brigham and Women's Hospital and the Veterans Affairs Boston Healthcare System have found that an online, team-based game designed to teach patients about diabetes self-management had a sustained and meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.